To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06482905
Title Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tcelltech Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic in Arizona NOT_YET_RECRUITING Phoenix Arizona 85054 United States Details
Mayo Clinic in Rochester NOT_YET_RECRUITING Rochester Minnesota 55905 United States Details
Beijing Tiantan Hospital RECRUITING Beijing Beijing 100730 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field